You have 9 free searches left this month | for more free features.

Histiocytoma

Showing 1 - 25 of 149

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Undifferentiated Pleomorphic Sarcoma Trial in Iowa City (Palbociclib, Pembrolizumab)

Not yet recruiting
  • Undifferentiated Pleomorphic Sarcoma
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Nov 1, 2023

Ewing Sarcoma, Myxoid Liposarcoma, Desmoplastic Small Round Cell Tumor Trial in Santa Monica (Seclidemstat)

Enrolling by invitation
  • Ewing Sarcoma
  • +8 more
  • Santa Monica, California
    Sarcoma Oncology Center
Feb 23, 2022

Rare Histiocytic Disorders (RHDs), Juvenile Xanthogranuloma (JXG), Reticulohistiocytoma (Epithelioid Histiocytoma) Trial in

Active, not recruiting
  • Rare Histiocytic Disorders (RHDs)
  • +7 more
  • Registry study
  • Los Angeles, California
  • +13 more
Dec 13, 2022

Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Myxofibrosarcoma Trial in Los Angeles (procedure, biological,

Recruiting
  • Leiomyosarcoma
  • +29 more
  • Definitive Surgical Resection
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Apr 26, 2022

Sarcoma, Advanced Sarcoma, High Grade Sarcoma Trial in New York (DCC-3014, Avelumab)

Active, not recruiting
  • Sarcoma
  • +6 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 26, 2022

Dermatofibroma of Skin Trial in Salt Lake City (1540 nanometer Erbium glass laser)

Completed
  • Dermatofibroma of Skin
  • 1540 nanometer Erbium glass laser
  • Salt Lake City, Utah
    University of Utah Dermatology
Jun 1, 2021

Undifferentiated Pleomorphic Sarcoma Trial in San Francisco (ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound

Recruiting
  • Undifferentiated Pleomorphic Sarcoma
  • ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound (MRgFUS)
  • San Francisco, California
    University of California, San Francisco
Feb 28, 2022

Locally Advanced Undifferentiated Pleomorphic Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma, Recurrent

Recruiting
  • Locally Advanced Undifferentiated Pleomorphic Sarcoma
  • +3 more
  • Sintilimab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Soft Tissue Sarcoma Adult, Undifferentiated Pleomorphic Sarcoma, Epithelioid Sarcoma Trial in Bordeaux (Trabectedin)

Recruiting
  • Soft Tissue Sarcoma Adult
  • +6 more
  • Bordeaux, France
    Institut Bergonie
Feb 1, 2022

Osteosarcoma, Bone Tumor, Bone Sarcoma Trial

Not yet recruiting
  • Osteosarcoma
  • +25 more
    • (no location specified)
    Aug 24, 2022

    Ewing Sarcoma, Myxoid Liposarcoma, Sarcoma,Soft Tissue Trial in United States (Seclidemstat, Cyclophosphamide, Topotecan)

    Recruiting
    • Ewing Sarcoma
    • +10 more
    • Los Angeles, California
    • +16 more
    Jan 18, 2022

    Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle

    Recruiting
    • Metastatic Leiomyosarcoma
    • +17 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 13, 2022

    Sarcoma, Soft Tissue Trial in Beijing (Recombinant anti-PD-1 humanized mAb injection)

    Not yet recruiting
    • Sarcoma, Soft Tissue
    • Recombinant anti-PD-1 humanized monoclonal antibody injection
    • Beijing, Beijing, China
      Beijing Jishuitan Hospital
    Dec 31, 2021

    Metastatic Extraskeletal Myxoid Chondrosarcoma, Metastatic Leiomyosarcoma, Metastatic Liposarcoma Trial (procedure, drug,

    Not yet recruiting
    • Metastatic Extraskeletal Myxoid Chondrosarcoma
    • +3 more
    • Biopsy
    • +6 more
    • (no location specified)
    Apr 25, 2023

    Sarcoma, Myxofibrosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in United States (Isolated Limb Infusion, Pembrolizumab,

    Recruiting
    • Sarcoma
    • +3 more
    • Isolated Limb Infusion
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Nov 21, 2022

    Sarcoma Trial in London (Pembrolizumab, Gemcitabine)

    Active, not recruiting
    • Sarcoma
    • London, United Kingdom
      Royal Marsden
    Jun 29, 2021

    Dedifferentiated Liposarcoma, Recurrent Dedifferentiated Liposarcoma, Recurrent Undifferentiated Pleomorphic Sarcoma Trial in

    Active, not recruiting
    • Dedifferentiated Liposarcoma
    • +5 more
    • Ipilimumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 25, 2022

    Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,

    Withdrawn
    • Soft Tissue Sarcoma
    • +12 more
    • Providence, Rhode Island
    • +1 more
    Nov 30, 2021

    Bone Sarcoma, Osteosarcoma, Ewing Sarcoma Trial in France (Treatment by Regorafenib, Treatment by Placebo)

    Recruiting
    • Bone Sarcoma
    • +6 more
    • Treatment by Regorafenib
    • Treatment by Placebo
    • Besançon, France
    • +15 more
    Aug 18, 2022

    Sarcoma, Soft Tissue Sarcoma, Metastatic Sarcoma Trial in Providence (Gemcitabine, Docetaxel, 9-ING-41)

    Withdrawn
    • Sarcoma
    • +12 more
    • Providence, Rhode Island
    • +1 more
    Jul 26, 2021

    Angiomatoid Fibrous Histiocytoma:Single Institution Case-series

    Completed
    • Angiomatoid Fibrous Histiocytoma
      • Bologna, Italy
        IRCC Rizzoli Orthopedic Institute
      Feb 11, 2020

      Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

      Active, not recruiting
      • Advanced Soft Tissue Sarcoma
      • +26 more
      • Doxorubicin Hydrochloride
      • +3 more
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Jan 6, 2023

      Sarcoma, Alveolar Soft Part Sarcoma, Clear Cell Sarcoma Trial in Warsaw (Hypofractionated radiotherapy, Hyperthermia)

      Active, not recruiting
      • Sarcoma
      • +10 more
      • Hypofractionated radiotherapy
      • Hyperthermia
      • Warsaw, Mazovian, Poland
        Maria Sklodowska-Curie Institute - Oncology Center
      Jan 27, 2021